The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ajer Jeffrey Robert since 2012.
This trader's CIK number is 1557533.
At the time of last reporting, Ajer Jeffrey Robert was the EVP, Chief Commercial Officer of Biomarin Pharmaceutical Inc. (stock ticker symbol BMRN).
Also see all insider trading activities at Biomarin Pharmaceutical Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BMRN | 0 | $0 | 9,000 | $762,830 | 0 | $0 |
| 2023 | BMRN | 0 | $0 | 54,000 | $6,129,296 | 49,000 | $3,322,690 |
| 2022 | BMRN | 0 | $0 | 19,689 | $1,653,318 | 0 | $0 |
| 2021 | BMRN | 0 | $0 | 8,417 | $638,393 | 0 | $0 |
| 2020 | BMRN | 0 | $0 | 24,724 | $2,626,766 | 15,000 | $946,500 |
| 2019 | BMRN | 0 | $0 | 11,903 | $1,079,904 | 0 | $0 |
| 2018 | BMRN | 0 | $0 | 22,741 | $1,995,799 | 9,000 | $567,900 |
| 2017 | BMRN | 0 | $0 | 18,203 | $1,697,385 | 8,007 | $281,773 |
| 2016 | BMRN | 0 | $0 | 19,722 | $1,876,618 | 0 | $0 |
| 2015 | BMRN | 0 | $0 | 40,409 | $4,925,947 | 36,631 | $1,212,590 |
| 2014 | BMRN | 0 | $0 | 32,563 | $2,644,317 | 29,370 | $895,071 |
| 2013 | BMRN | 0 | $0 | 28,474 | $1,862,403 | 25,026 | $491,545 |
| 2012 | BMRN | 0 | $0 | 6,181 | $298,569 | 5,916 | $106,014 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NKTR | 0 | $0 | 4,359 | $3,007 | 0 | $0 |
| 2022 | NKTR | 0 | $0 | 4,198 | $13,265 | 0 | $0 |
| 2021 | NKTR | 0 | $0 | 3,665 | $65,163 | 0 | $0 |
| 2020 | NKTR | 0 | $0 | 5,500 | $100,477 | 0 | $0 |
| 2019 | NKTR | 0 | $0 | 4,625 | $88,432 | 0 | $0 |
| 2018 | NKTR | 0 | $0 | 6,750 | $383,130 | 0 | $0 |
1. Biomarin Pharmaceutical Inc (BMRN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-02 | BMRN | Sale | 5,000 | 82.91 | 414,550 |
| 2024-03-05 | BMRN | Sale | 4,000 | 87.07 | 348,280 |
| 2023-08-16 | BMRN | Sale | 5,000 | 90.00 | 450,000 |
| 2023-01-25 | BMRN | Sale | 49,000 | 115.90 | 5,679,296 |
| 2023-01-25 | BMRN | Option Ex | 49,000 | 67.81 | 3,322,690 |
| 2022-11-02 | BMRN | Sale | 3,000 | 86.12 | 258,360 |
| 2022-08-11 | BMRN | Sale | 3,000 | 95.62 | 286,860 |
| 2022-05-26 | BMRN | Sale | 1,308 | 78.94 | 103,253 |
| 2022-04-13 | BMRN | Sale | 1,180 | 82.47 | 97,314 |
| 2022-03-30 | BMRN | Sale | 1,381 | 79.56 | 109,872 |
| 2022-03-29 | BMRN | Sale | 1,618 | 79.43 | 128,517 |
| 2022-03-22 | BMRN | Sale | 2,073 | 81.00 | 167,913 |
| 2022-03-23 | BMRN | Sale | 6,129 | 81.78 | 501,229 |
| 2021-10-26 | BMRN | Sale | 2,739 | 73.60 | 201,590 |
| 2021-04-08 | BMRN | Sale | 1,537 | 78.81 | 121,130 |
| 2021-03-30 | BMRN | Sale | 1,652 | 74.79 | 123,553 |
| 2021-03-24 | BMRN | Sale | 1,181 | 76.30 | 90,110 |
| 2021-03-18 | BMRN | Sale | 1,308 | 77.99 | 102,010 |
| 2020-10-14 | BMRN | Sale | 2,121 | 79.91 | 169,489 |
| 2020-06-19 | BMRN | Sale | 15,000 | 124.00 | 1,860,000 |
| 2020-06-19 | BMRN | Option Ex | 15,000 | 63.10 | 946,500 |
| 2020-04-08 | BMRN | Sale | 2,407 | 79.98 | 192,511 |
| 2020-04-01 | BMRN | Sale | 1,537 | 82.00 | 126,034 |
| 2020-03-24 | BMRN | Sale | 2,041 | 74.36 | 151,768 |
| 2020-03-25 | BMRN | Sale | 1,618 | 78.47 | 126,964 |
| 2019-03-26 | BMRN | Sale | 3,656 | 89.17 | 326,023 |
| 2019-03-21 | BMRN | Sale | 4,519 | 90.05 | 406,917 |
| 2019-03-19 | BMRN | Sale | 3,728 | 93.07 | 346,964 |
| 2018-11-14 | BMRN | Option Ex | 9,000 | 63.10 | 567,900 |
| 2018-11-14 | BMRN | Sale | 9,000 | 93.00 | 836,973 |
| 2018-10-03 | BMRN | Sale | 1,000 | 98.98 | 98,985 |
| 2018-06-11 | BMRN | Sale | 1,436 | 90.31 | 129,685 |
| 2018-05-07 | BMRN | Sale | 309 | 85.96 | 26,561 |
| 2018-04-02 | BMRN | Sale | 2,119 | 80.12 | 169,774 |
| 2018-03-29 | BMRN | Sale | 1,537 | 79.69 | 122,483 |
| 2018-03-21 | BMRN | Sale | 4,368 | 83.90 | 366,475 |
| 2018-03-09 | BMRN | Sale | 2,972 | 82.39 | 244,863 |
| 2017-09-22 | BMRN | Sale | 3,521 | 95.00 | 334,495 |
| 2017-09-22 | BMRN | Option Ex | 3,521 | 37.46 | 131,896 |
| 2017-06-07 | BMRN | Sale | 1,004 | 89.61 | 89,968 |
| 2017-05-05 | BMRN | Option Ex | 4,486 | 33.41 | 149,877 |
| 2017-05-05 | BMRN | Sale | 4,486 | 99.00 | 444,114 |
| 2017-05-02 | BMRN | Sale | 302 | 96.74 | 29,215 |
| 2017-03-29 | BMRN | Sale | 3,890 | 89.15 | 346,793 |
| 2017-03-07 | BMRN | Sale | 5,000 | 90.56 | 452,800 |
| 2016-09-27 | BMRN | Sale | 18,467 | 95.61 | 1,765,648 |
| 2016-03-04 | BMRN | Sale | 1,255 | 88.42 | 110,970 |
| 2015-11-02 | BMRN | Sale | 26 | 117.56 | 3,056 |
| 2015-07-20 | BMRN | Sale | 3,000 | 150.00 | 450,000 |
| 2015-07-20 | BMRN | Option Ex | 3,000 | 63.10 | 189,300 |
| 2015-06-04 | BMRN | Sale | 1,362 | 122.35 | 166,646 |
| 2015-06-01 | BMRN | Sale | 377 | 123.76 | 46,656 |
| 2015-05-26 | BMRN | Sale | 1,625 | 126.55 | 205,647 |
| 2015-05-06 | BMRN | Sale | 34,019 | 119.17 | 4,053,942 |
| 2015-05-06 | BMRN | Option Ex | 33,631 | 30.43 | 1,023,290 |
| 2014-12-03 | BMRN | Option Ex | 12,000 | 38.59 | 463,080 |
| 2014-12-03 | BMRN | Sale | 12,000 | 91.01 | 1,092,156 |
| 2014-11-03 | BMRN | Sale | 47 | 83.54 | 3,926 |
| 2014-06-02 | BMRN | Sale | 377 | 57.84 | 21,803 |
| 2014-05-16 | BMRN | Sale | 1,004 | 56.91 | 57,135 |
| 2014-05-13 | BMRN | Sale | 478 | 58.18 | 27,809 |
| 2014-05-09 | BMRN | Sale | 621 | 57.96 | 35,991 |
| 2014-05-01 | BMRN | Sale | 666 | 59.55 | 39,660 |
| 2014-03-06 | BMRN | Option Ex | 17,370 | 24.87 | 431,991 |
| 2014-03-06 | BMRN | Sale | 17,370 | 78.63 | 1,365,837 |
| 2013-12-09 | BMRN | Option Ex | 13,026 | 17.92 | 233,425 |
| 2013-12-09 | BMRN | Sale | 13,026 | 69.55 | 906,010 |
| 2013-11-01 | BMRN | Sale | 99 | 63.16 | 6,252 |
| 2013-06-03 | BMRN | Sale | 493 | 58.34 | 28,763 |
| 2013-05-13 | BMRN | Sale | 1,248 | 69.25 | 86,430 |
| 2013-05-09 | BMRN | Sale | 811 | 66.00 | 53,528 |
| 2013-05-01 | BMRN | Sale | 797 | 64.52 | 51,420 |
| 2013-04-19 | BMRN | Option Ex | 5,000 | 21.51 | 107,550 |
| 2013-04-19 | BMRN | Sale | 5,000 | 65.00 | 325,000 |
| 2013-03-04 | BMRN | Option Ex | 4,000 | 21.51 | 86,040 |
| 2013-03-04 | BMRN | Sale | 4,000 | 60.00 | 240,000 |
| 2013-01-22 | BMRN | Option Ex | 3,000 | 21.51 | 64,530 |
| 2013-01-22 | BMRN | Sale | 3,000 | 55.00 | 165,000 |
| 2012-11-28 | BMRN | Sale | 5,916 | 48.31 | 285,819 |
| 2012-11-28 | BMRN | Option Ex | 5,916 | 17.92 | 106,014 |
| 2012-11-12 | BMRN | Sale | 265 | 48.11 | 12,750 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-18 | NKTR | Sale | 4,359 | .69 | 3,007 |
| 2022-09-23 | NKTR | Sale | 4,198 | 3.16 | 13,265 |
| 2021-09-22 | NKTR | Sale | 3,665 | 17.78 | 65,163 |
| 2020-09-28 | NKTR | Sale | 3,250 | 17.25 | 56,062 |
| 2020-09-21 | NKTR | Sale | 2,250 | 19.74 | 44,415 |
| 2019-09-30 | NKTR | Sale | 2,375 | 18.06 | 42,892 |
| 2019-09-20 | NKTR | Sale | 2,250 | 20.24 | 45,540 |
| 2018-09-20 | NKTR | Sale | 6,750 | 56.76 | 383,130 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ajer Jeffrey Robert (EVP, Chief Commercial Officer of Biomarin Pharmaceutical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.